sb 202190 has been researched along with Teratocarcinoma in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Teratocarcinoma: A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamagishi, N | 1 |
| Saito, Y | 1 |
| Ishihara, K | 1 |
| Hatayama, T | 1 |
1 other study available for sb 202190 and Teratocarcinoma
| Article | Year |
|---|---|
Enhancement of oxidative stress-induced apoptosis by Hsp105alpha in mouse embryonal F9 cells.
Topics: Animals; Apoptosis; Caspases; Cytochrome c Group; DNA Fragmentation; DNA, Complementary; Embryonic a | 2002 |